FindTrial
Sign In

Efficacy and Safety of Transcatheter Therapy for Tricuspid Regurgitation: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Transcatheter Therapy for Tricuspid Regurgitation: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials - Efficacy and Safety of Transcatheter Therapy for Tricuspid Regurgitation: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000056729
Enrollment
400
Registered
2025-01-16
Start date
2025-01-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tricuspid Regurgitation

Interventions

None listed

Sponsors

Hirosaki University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) focused on patients with moderate to severe tricuspid regurgitation; 2) evaluated transcatheter therapies, including edge-to-edge repair, annuloplasty devices, or valve replacement; 3) provided quantitative data on efficacy and safety; and 4) only RCTs were considered for inclusion

Exclusion criteria

Exclusion criteria: 1) compared transcatheter therapy with surgical treatments; 2) were single-arm studies; or 3) constituted subgroup analyses of previous studies

Design outcomes

Primary

MeasureTime frame
Efficiency—

Countries

Japan,Asia(except Japan),North America,South America,Australia,Europe,Africa

Contacts

Public ContactZaiqiang Yu

Hirosaki University Department of Thoracic and Cardiovascular Surgery

yuzaiqiang@hirosaki-u.ac.jp0172-33-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026